Navigation Links
B. Melina Cimler, PhD, Former Senior Vice President of Regulatory & Quality at Adaptive Biotechnologies, Joins NDA Partners
Date:9/27/2018

NDA Partners Chairman Carl Peck, MD, announced today that Dr. B. Melina Cimler, a senior quality, regulatory, and in vitro diagnostic device expert with more than 28 years of experience in the life science and FDA-regulated global diagnostic industry has joined the firm as an Expert Consultant. Her experience includes leadership roles in regulatory strategy, quality systems, clinical affairs, research, and product development organizations with a focus on precision medicine.

Prior to joining NDA Partners, Dr. Cimler served as Senior Vice President of Regulatory and Quality at Adaptive Biotechnologies. She was formerly Head of Global Quality and Vice President of Quality, Regulatory, Clinical, and Government Affairs at Illumina Inc., where she defined and executed the regulatory strategy for the first next generation sequencing platform (MiSeqDx) to receive FDA marketing authorization.

Dr. Cimler has also previously held executive leadership positions in quality management, regulatory affairs, clinical development, and government affairs at Abbott Molecular, Beckman Coulter Inc., Gen-Probe Inc., and CR Bard, Inc., and she was formerly head of Product Development at Epitope, Inc. (now OraSure Technologies, Inc.).

According to Dr. David Feigal, NDA Partners’ Medical Device Practice Manager, “Dr. Cimler’s expertise in regulatory strategies, quality management, clinical affairs, and product development, focus on precision medicine, and experience in the global in vitro diagnostic industry makes her a welcome addition to our team of Expert Consultants. We are very pleased that she has joined NDA Partners.”

Dr. Cimler earned her doctoral degree in pharmacology and her bachelor’s degrees in biology and chemistry from the University of Washington. She currently serves on the Board of Directors of Nanostics, Inc. and is a Scientific Board member of M3 Biotechnology.

About NDA Partners
NDA Partners is a life sciences management consulting firm focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Premier Experts of NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and management of client product development programs.

Contact
Earle Martin, Chief Executive Officer
Office: 540-738-2550
MartinEarle(at)ndapartners.com

Read the full story at https://www.prweb.com/releases/b_melina_cimler_phd_former_senior_vice_president_of_regulatory_quality_at_adaptive_biotechnologies_joins_nda_partners/prweb15750970.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, Former Head of Roche Molecular Diagnostics
2. John W. Sheets Jr., Former FDA Director Of The Office Of Device Evaluation, Joins NDA Partners As Expert Consultant
3. Former VP of Clinical Pharmacology at Nektar Therapeutics, Michael A. Eldon, PhD, FCP, Joins NDA Partners as Expert Consultant
4. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
5. Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
6. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
7. Former FDA Official to Conduct Popular ComplianceOnline Seminar on FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
8. Former P&G VP Appointed New Industry Expert at Verixs Advisory Board
9. Former Director of FDA Division of Biostatistics, Gregory Campbell, PhD, joins NDA Partners as Expert Consultant
10. Vinod Shah, PhD, Former Senior Research Scientist in FDA Office of Pharmaceutical Sciences, Joins NDA Partners as Expert Consultant
11. Former Allergan Chief David Pyott Signs on as Special Advisor to Sienna Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, radiation and ... led to the advent of Chimeric Antigen Receptor T (CAR T) cell therapy, which ... The CAR enables the final product to produce chemicals in the hopes that the ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... the first to demonstrate an efficient delivery system for the sustained release of ... The platelet-rich plasma-based gel system was able to deliver CM into the injured ...
(Date:5/15/2019)... RIVER FALLS, Wis. (PRWEB) , ... May 16, ... ... uniform oil and water mixtures. As a result, food and beverage products rely ... However, today, consumers demand more natural sounding label declarations. This paradigm shift triggers ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen ... repositories being asked to store cellular products being used in adoptive therapy ... are world leaders, who have shared their expertise in building and managing facilities ...
Breaking Biology Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... ... the Southeast, and its acclaimed pediatric urologists are among the professionals honored ... annual recognition signifies excellence among the country’s pediatric healthcare landscape. , Georgia ...
(Date:7/11/2019)... ... July 11, 2019 , ... ... Legionella DNA test, today announced a partnership with LiquiTech, a leader in ... this strategic partnership, LiquiTech will integrate Spartan’s innovative environmental DNA testing platform ...
(Date:7/9/2019)... Del. (PRWEB) , ... July 08, 2019 , ... ... Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco ... that an entitlement action could be based on prior art was without merit ...
Breaking Biology News(10 mins):